Consistent with these findings, AKT1 activation appears to be required for BCC tumorigenesis in a SKH1-Ptch1+/− mouse model that resembles features of patients with Basal Cell Nevus Syndrome. Here, AKT1 is linked to skin basal cell carcinoma.